Vireo Growth Inc.

CNSX:VREO Voorraadrapport

Marktkapitalisatie: CA$142.8m

Vireo Growth Toekomstige groei

Future criteriumcontroles 0/6

Vireo Growth's revenue is forecast to decline at 1.4% per annum.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Pharmaceuticals winstgroei54.4%
Inkomstengroei-1.4%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Low

Laatst bijgewerkt07 Aug 2024

Recente toekomstige groei-updates

Recent updates

Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Oct 12
Vireo Growth Inc.'s (CSE:VREO) 29% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Aug 10
Vireo Growth Inc. (CSE:VREO) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected

Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Jun 01
Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost

Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Apr 06
Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company

Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Feb 01
Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump

Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Dec 14
Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt

Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Jul 14
Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?

Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Mar 19
Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?

Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Jan 25
Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?

Winst- en omzetgroeiprognoses

CNSX:VREO - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/202596N/AN/A-111
12/31/202497N/AN/A-61
6/30/202498-17-80N/A
3/31/202493-24-52N/A
12/31/202388-26-7-1N/A
9/30/202383-34-11-7N/A
6/30/202377-37-15-10N/A
3/31/202378-36-19-15N/A
12/31/202275-42-23-18N/A
9/30/202269-43-28-20N/A
6/30/202264-41-34-23N/A
3/31/202257-41-47-32N/A
12/31/202154-34-49-31N/A
9/30/202153-22-42-23N/A
6/30/202152-13-39-21N/A
3/31/202150-22-26-13N/A
12/31/202049-23-19-11N/A
9/30/202048-63-27-22N/A
6/30/202042-78-30-25N/A
3/31/202036-62-35-28N/A
12/31/201930-57-35-27N/A
9/30/201925-17-26-19N/A
6/30/201922-4-22-17N/A
3/31/201921-4-13-10N/A
12/31/201818-3-11-9N/A
9/30/201816-2-13-6N/A
12/31/2017110N/A-1N/A
12/31/201646N/A-4N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Insufficient data to determine if VREO's forecast earnings growth is above the savings rate (2.2%).

Winst versus markt: Insufficient data to determine if VREO's earnings are forecast to grow faster than the Canadian market

Hoge groeiwinsten: Insufficient data to determine if VREO's earnings are expected to grow significantly over the next 3 years.

Omzet versus markt: VREO's revenue is expected to decline over the next 3 years (-1.4% per year).

Hoge groei-inkomsten: VREO's revenue is forecast to decline over the next 3 years (-1.4% per year).

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Insufficient data to determine if VREO's Return on Equity is forecast to be high in 3 years time

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y